The Trump administration has approved a $2.8 billion weapons package for Israel that includes 40,000 of the most destructive bombs in the U.S. arsenal.
Story Snapshot
- The deal covers 20,000 MK 84 bombs and 20,000 BLU-117 bombs, each weighing 2,000 pounds.
- A U.S. official confirmed the sale to Reuters, marking one of the largest munitions transfers to Israel in years.
- The package follows a pattern of Trump administration arms sales to Israel that started in early 2025.
- Some of these earlier sales bypassed the normal 30-day congressional review window using emergency authority.
What The New Package Actually Contains
A U.S. official familiar with the sale told Reuters the Trump administration is moving forward with a $2.8 billion munitions package for Israel.
The order includes 20,000 MK 84 bombs and 20,000 BLU-117 bombs, both 2,000-pound weapons known for their blast radius and ability to punch through hardened structures. The Washington Examiner reported the sale advanced this week, calling it one of the largest U.S. weapons deals with Jerusalem in recent memory.
The order size stands out. Forty thousand heavy bomb bodies is a massive quantity for a single package, even by the standards of U.S.-Israel arms cooperation.
Reporting on the deal noted it eclipses many previous munitions sales in scope, reflecting both Israel’s ongoing military operations and the administration’s willingness to restock its ally’s arsenal quickly.
The Trump administration is preparing a $2.8 billion arms package for Israel, including several thousand 2,000-pound bombs, in what would be the largest single U.S. sale of the powerful munitions to Israel in recent years. https://t.co/ZSknqZIbEg
— NEWSMAX (@NEWSMAX) September 16, 2026
A Deal Years In The Making, Not A One-Off Purchase
This is not the first large bomb sale the Trump administration has pushed through for Israel. In February 2025, the State Department declared an emergency to bypass congressional review and notified Congress of sales worth roughly $2.04 billion, covering more than 35,000 MK 84 or BLU-117 bomb bodies and thousands of penetrator warheads. That earlier package set the stage for the pattern now playing out again.
By March 2025, the administration used emergency authority a second time to push through a sale of more than 20,000 bombs worth about $650 million, again skipping the standard congressional review period.
Secretary of State Marco Rubio said publicly that he used emergency powers under U.S. law to speed roughly $4 billion in military assistance to Israel, waiving the review requirements Congress normally gets to use. The new $2.8 billion package builds directly on that groundwork.
Why Congress Usually Gets A Say, And Why That Sometimes Gets Skipped
Under the Arms Export Control Act, the president must give Congress 30 days’ notice before finalizing a major foreign military sale of significant defense equipment.
That review window lets lawmakers object, delay, or in rare cases block a sale before it becomes final. It exists so elected representatives, not just the executive branch, can check where American weapons end up.
The law also lets a president waive that review if he declares an emergency exists. Both the Biden and Trump administrations have used that waiver for Israel sales, a fact that has drawn criticism from watchdog groups who argue the “emergency” label gets stretched thin when used repeatedly over consecutive years. Whatever one thinks of that debate, the legal path itself is well established and has bipartisan precedent.
Israel has long been the most frequent recipient of major American arms packages, accounting for a large share of all U.S. Foreign Military Sales agreements over the past several decades.
Congressional records show the Trump administration notified lawmakers of $8.4 billion in sales to Israel in a single batch back in February 2025, underscoring how routine large-scale support has become even as individual packages draw public attention.
The Political and Public Reaction Taking Shape
News of the $2.8 billion sale has generated sharp reaction online, with critics questioning the scale of bomb shipments while supporters point to Israel’s right to defend itself against ongoing threats.
Commentary from figures across the political spectrum has amplified the story well beyond typical defense-trade coverage, a sign that arms sales to Israel remain one of the most closely watched foreign policy issues in Washington.
#RWorldNews
US Approves Bomb Sale to Israel Trump administration approves $2.8B arms package: 40,000 bombs for Israel, raising civilian casualty concerns. #Israel #USArmsDeal #MiddleEast pic.twitter.com/LgIUmtJAvt— Triple R (@RaviRRana) September 16, 2026
Supporters of the sale argue that keeping a close ally stocked with modern munitions serves core American interests in a volatile region. Restocking Israel’s arsenal also supports domestic defense manufacturing, an industry that directly benefits from sustained government-to-government sales. The administration has framed these packages as routine support for a strategic partner facing persistent security threats.
Sources:
nbcnews.com, reuters.com, washingtonexaminer.com, media.defense.gov, forumarmstrade.org, responsiblestatecraft.org, fdd.org, congress.gov
